DK0462551T3 - Monoklonale antistoffer mod HIV gp120 - Google Patents

Monoklonale antistoffer mod HIV gp120

Info

Publication number
DK0462551T3
DK0462551T3 DK91109937.2T DK91109937T DK0462551T3 DK 0462551 T3 DK0462551 T3 DK 0462551T3 DK 91109937 T DK91109937 T DK 91109937T DK 0462551 T3 DK0462551 T3 DK 0462551T3
Authority
DK
Denmark
Prior art keywords
monoclonal antibodies
hiv
antibodies
amino acid
provides
Prior art date
Application number
DK91109937.2T
Other languages
English (en)
Inventor
Jade Chin
Mary S Gibadlo
W Gerard Robey
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24153675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0462551(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0462551T3 publication Critical patent/DK0462551T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK91109937.2T 1990-06-18 1991-06-18 Monoklonale antistoffer mod HIV gp120 DK0462551T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54002590A 1990-06-18 1990-06-18

Publications (1)

Publication Number Publication Date
DK0462551T3 true DK0462551T3 (da) 1996-02-12

Family

ID=24153675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91109937.2T DK0462551T3 (da) 1990-06-18 1991-06-18 Monoklonale antistoffer mod HIV gp120

Country Status (10)

Country Link
EP (1) EP0462551B1 (da)
JP (1) JPH04299993A (da)
KR (1) KR920000333A (da)
AT (1) ATE128733T1 (da)
AU (1) AU651113B2 (da)
CA (1) CA2044741A1 (da)
DE (1) DE69113520T2 (da)
DK (1) DK0462551T3 (da)
ES (1) ES2080193T3 (da)
GR (1) GR3018082T3 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP237A (en) * 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
EP0554401A4 (en) * 1990-10-26 1996-10-30 New York Health Res Inst Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
US5556744A (en) * 1992-05-29 1996-09-17 The Trustees Of The University Of Pennsylvania Methods and compositions for diagnosing and treating certain HIV infected patients
EP4051318A4 (en) * 2019-10-29 2023-10-11 International AIDS Vaccine Initiative ENGINEERED ANTI-ENV HIV ANTIBODIES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0511967B1 (en) * 1990-01-26 1996-02-28 Bay Development Corporation Sa Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies

Also Published As

Publication number Publication date
JPH04299993A (ja) 1992-10-23
ES2080193T3 (es) 1996-02-01
EP0462551B1 (en) 1995-10-04
EP0462551A1 (en) 1991-12-27
DE69113520T2 (de) 1996-05-09
AU7847591A (en) 1991-12-19
ATE128733T1 (de) 1995-10-15
DE69113520D1 (de) 1995-11-09
KR920000333A (ko) 1992-01-29
CA2044741A1 (en) 1991-12-19
GR3018082T3 (en) 1996-02-29
AU651113B2 (en) 1994-07-14

Similar Documents

Publication Publication Date Title
DE69433422D1 (de) Monoklonaler anti-hiv antikörper
EP0675904A4 (en) HUMANE NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE VIRUS FROM HUMAN THAT MAKES THE IMMUNE.
NO991591D0 (no) Rekonstituert human anti-HM1.24 antistoff
EP0724651A4 (en) SYNTHETIC HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE VIRUS FROM HUMAN INITIATING THE IMMUNITY
HUT60512A (en) Process for producing polyethylene glycol conjugates of proteins
ATE122237T1 (de) Hiv-1 neutralisierende monoklonale antikörper.
EP1020522A4 (en) NATURAL HUMAN ANTIBODY
EP0673255A4 (en) MONOCLONAL ANTIBODY, WHICH SPECIFICALLY BINDS TO VASCULARIZED TUMOR DOTHELIUM AND USES THEREOF.
AU8010791A (en) Hiv monoclonal antibody
DE69113520D1 (de) Monoklonale Antikörper gegen HIV GP120.
DK0585570T3 (da) Granulocytbindende antistofkonstrukter, deres fremstilling og anvendelse
DK0516135T3 (da) Humant immundefektvirus-relateret immunpræparat
DK0541753T3 (da) Hidtil ukendt hybrid, opløselig og ikke-spaltelig gp160-variant
DK0472706T3 (da) Induktion af beskyttelse mod viral infektion
DK0732339T3 (da) Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf
WO1989009227A3 (fr) Peptides pf10 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
NZ508812A (en) Peptides for the prevention or treatment of HIV
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline
AU627540B2 (en) Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof
DE68926454D1 (de) Gegen hiv 1 gp48 spezifische antikörper
WO2000001719A3 (en) Peptides from varicella-zoster and other viruses for hiv-2 diagnosis and therapy